Inventor · disambiguated record
Deborah Law
Also filed as: LAW DEBORAH · LAW DEBORAH A · LAW DEBORAH ANN
4 granted patents·7 pending applications·12 citations·filing 1996–2022
66Inventor score
Top patents by PatentIndex Score
11 records- 0180US11292840B2Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonistJOUNCE THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·3 cites·19 claims
- 0262US2022332823A1Methods of treating cancerJOUNCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0360US2022281978A1Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing)JOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0456US11052065B2Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonistMERCK SHARP & DOHME·Filed 2018·Granted Jul 6, 2021·0 cites·11 claims
- 0548US6210913B1Modulation of integrin-mediated signal transductionCOR THERAPEUTICS INC·Filed 1996·Granted Apr 3, 2001·9 cites·7 claims
- 0645US2020024351A1Compositions and Methods for the Treatment of CancerJOUNCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0744US2021353750A1Methods of Treating CancerJOUNCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0844US2021355222A1Methods of Treating CancerJOUNCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0942US2021380942A1Methods and compositions for the treatment of cancer and infectious diseasesJOUNCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1040US2003059852A1Modulation of integrin-mediated signal transductionCOR THERAPEUTICS INC·Filed 2001·Application pending·0 cites
- 1127US6995298B1Transgenic mammals expressing mutant GP IIIaMILLENNIUM PHARM INC·Filed 1998·Granted Feb 7, 2006·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Deborah Law files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →